NITROGLYCERIN

Nitroglycerin Adverse Events Reported to the FDA Over Time

How are Nitroglycerin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nitroglycerin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nitroglycerin is flagged as the suspect drug causing the adverse event.

Most Common Nitroglycerin Adverse Events Reported to the FDA

What are the most common Nitroglycerin adverse events reported to the FDA?

Hypotension	137 (2.19%)
Drug Ineffective	94 (1.5%)
Completed Suicide	84 (1.34%)
Chest Pain	78 (1.25%)
Dyspnoea	74 (1.18%)
Syncope	71 (1.14%)
Myocardial Infarction	67 (1.07%)
Fall	58 (.93%)
Dehydration	54 (.86%)
Nausea	53 (.85%)
Confusional State	52 (.83%)
	Show More
Headache	52 (.83%)
Drug Interaction	49 (.78%)
Loss Of Consciousness	48 (.77%)
Asthenia	47 (.75%)
Dizziness	47 (.75%)
Pain	45 (.72%)
Renal Failure Acute	43 (.69%)
Circulatory Collapse	40 (.64%)
Cardiac Arrest	37 (.59%)
Cerebrovascular Accident	36 (.58%)
Death	36 (.58%)
Hypertension	36 (.58%)
Anxiety	35 (.56%)
Back Pain	35 (.56%)
Chronic Obstructive Pulmonary Disea...	34 (.54%)
General Physical Health Deteriorati...	34 (.54%)
Hallucination	34 (.54%)
Pyrexia	34 (.54%)
Hyperhidrosis	31 (.5%)
Convulsion	30 (.48%)
Multiple Myeloma	30 (.48%)
Myoclonus	30 (.48%)
Aortic Aneurysm	29 (.46%)
Dysphagia	29 (.46%)
Haematuria	29 (.46%)
Sepsis	29 (.46%)
Vision Blurred	29 (.46%)
Blood Calcium Decreased	28 (.45%)
Pruritus	28 (.45%)
Blood Immunoglobulin G Increased	27 (.43%)
Decreased Interest	27 (.43%)
Feeling Abnormal	27 (.43%)
Localised Infection	27 (.43%)
Malaise	27 (.43%)
Osteomyelitis	27 (.43%)
Paraplegia	27 (.43%)
Renal Failure Chronic	27 (.43%)
Sleep Disorder Due To A General Med...	27 (.43%)
Squamous Cell Carcinoma Of Skin	27 (.43%)
Astigmatism	26 (.42%)
Glaucoma	26 (.42%)
Pancytopenia	26 (.42%)
Renal Failure	26 (.42%)
Abnormal Sensation In Eye	25 (.4%)
Blepharitis	25 (.4%)
Eye Naevus	25 (.4%)
Hypermetropia	25 (.4%)
Hypersensitivity	25 (.4%)
Myeloma Recurrence	25 (.4%)
Optic Nerve Cupping	25 (.4%)
Plasmacytosis	25 (.4%)
Vesical Fistula	25 (.4%)
Cardiac Failure	24 (.38%)
Dyspepsia	24 (.38%)
Intervertebral Disc Degeneration	24 (.38%)
Musculoskeletal Pain	24 (.38%)
Peroneal Nerve Palsy	24 (.38%)
Scar	24 (.38%)
Vomiting	24 (.38%)
Anaemia Of Chronic Disease	23 (.37%)
Haematoma	23 (.37%)
Impaired Healing	23 (.37%)
Osteoarthritis	23 (.37%)
Overdose	23 (.37%)
Protein Urine Present	23 (.37%)
Angina Pectoris	22 (.35%)
Bone Disorder	22 (.35%)
Condition Aggravated	22 (.35%)
Diverticulum	22 (.35%)
Lethargy	22 (.35%)
Bladder Cancer	21 (.34%)
Bradycardia	21 (.34%)
Decubitus Ulcer	21 (.34%)
Foot Deformity	21 (.34%)
Pneumonia	21 (.34%)
Respiratory Distress	21 (.34%)
Urinary Tract Infection	21 (.34%)
Diabetes Mellitus	20 (.32%)
Gastrointestinal Haemorrhage	20 (.32%)
Medication Error	20 (.32%)
Acute Myocardial Infarction	19 (.3%)
Blood Pressure Decreased	19 (.3%)
Orthostatic Hypotension	19 (.3%)
Abdominal Pain	18 (.29%)
Angina Unstable	18 (.29%)
Bronchitis	18 (.29%)
Chills	18 (.29%)
Gastric Ulcer	18 (.29%)
Hypercalcaemia Of Malignancy	18 (.29%)
Metabolic Acidosis	18 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Nitroglycerin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nitroglycerin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nitroglycerin

What are the most common Nitroglycerin adverse events reported to the FDA?

Neurological	358 (5.73%)
Epidermal And Dermal Conditions	222 (3.55%)
Decreased And Nonspecific Blood Pre...	213 (3.41%)
Respiratory	187 (2.99%)
Coronary Artery	186 (2.98%)
Infections - Pathogen Unspecified	185 (2.96%)
Cardiac Arrhythmias	176 (2.82%)
Therapeutic And Nontherapeutic Effe...	176 (2.82%)
Gastrointestinal Signs	165 (2.64%)
Cardiac And Vascular Investigations	123 (1.97%)
Renal Disorders	122 (1.95%)
	Show More
Injuries	121 (1.94%)
Vision	102 (1.63%)
Medication Errors	98 (1.57%)
Electrolyte And Fluid Balance Condi...	93 (1.49%)
Suicidal And Self-injurious Behavio...	87 (1.39%)
Musculoskeletal And Connective Tiss...	78 (1.25%)
Deliria	70 (1.12%)
Central Nervous System Vascular	68 (1.09%)
Skin Appendage Conditions	67 (1.07%)
Anemias Nonhemolytic And Marrow Dep...	63 (1.01%)
Bone And Joint Therapeutic Procedur...	63 (1.01%)
Headaches	61 (.98%)
Anxiety Disorders	58 (.93%)
Musculoskeletal And Connective Tiss...	56 (.9%)
Plasma Cell Neoplasms	55 (.88%)
Lower Respiratory Tract Disorders	54 (.86%)
Bronchial Disorders	50 (.8%)
Hematology Investigations	50 (.8%)
Seizures	50 (.8%)
Hepatic And Hepatobiliary	49 (.78%)
Allergic Conditions	48 (.77%)
Water, Electrolyte And Mineral	47 (.75%)
Bacterial Infectious	46 (.74%)
Heart Failures	45 (.72%)
Joint	45 (.72%)
Physical Examination Topics	45 (.72%)
Urinary Tract Signs	45 (.72%)
Renal And Urinary Tract Investigati...	44 (.7%)
Chemical Injury And Poisoning	42 (.67%)
Psychiatric	42 (.67%)
Disturbances In Thinking	39 (.62%)
Vascular Hypertensive	39 (.62%)
Body Temperature Conditions	36 (.58%)
Bone And Joint Injuries	36 (.58%)
Fatal Outcomes	36 (.58%)
Depressed Mood Disorders	35 (.56%)
Movement Disorders	35 (.56%)
Muscle	35 (.56%)
Sleep Disorders	35 (.56%)
Bone Disorders	34 (.54%)
White Blood Cell	34 (.54%)
Gastrointestinal Motility And Defec...	33 (.53%)
Ocular Infections, Irritations And ...	33 (.53%)
Immunology And Allergy	32 (.51%)
Procedural And Device Related Injur...	32 (.51%)
Vascular	32 (.51%)
Arteriosclerosis, Stenosis, Vascula...	31 (.5%)
Cardiac Disorder Signs	31 (.5%)
Gastrointestinal Hemorrhages	30 (.48%)
Vascular Hemorrhagic	30 (.48%)
Aneurysms And Artery Dissections	29 (.46%)
Appetite And General Nutritional	28 (.45%)
Glaucoma And Ocular Hypertension	27 (.43%)
Glucose Metabolism Disorders	27 (.43%)
Ocular Structural Change, Deposit A...	27 (.43%)
Skin Neoplasms Malignant And Unspec...	27 (.43%)
Gastrointestinal Ulceration And Per...	26 (.42%)
Peripheral Neuropathies	26 (.42%)
Acid-base	25 (.4%)
Bladder And Bladder Neck Disorders	25 (.4%)
Myocardial	25 (.4%)
Ocular Neoplasms	25 (.4%)
Ocular Sensory Symptoms	25 (.4%)
Product Quality Issues	25 (.4%)
Administration Site Reactions	24 (.38%)
Mental Impairment	24 (.38%)
Tissue	24 (.38%)
Upper Respiratory Tract Disorders	24 (.38%)
Diverticular	22 (.35%)
Hepatobiliary	22 (.35%)
Viral Infectious	22 (.35%)
Renal And Urinary Tract Neoplasms M...	21 (.34%)
Spinal Cord And Nerve Root	21 (.34%)
Angiedema And Urticaria	20 (.32%)
Enzyme	19 (.3%)
Therapeutic Procedures And Supporti...	19 (.3%)
Neoplastic And Ectopic Endocrinopat...	18 (.29%)
Platelet	18 (.29%)
Gastrointestinal Stenosis And Obstr...	17 (.27%)
Hematological And Lymphoid Tissue T...	17 (.27%)
Head And Neck Therapeutic Procedure...	16 (.26%)
Metabolic, Nutritional And Blood Ga...	16 (.26%)
Lifestyle Issues	15 (.24%)
Lipid Analyses	15 (.24%)
Cutaneous Neoplasms Benign	14 (.22%)
Gallbladder	14 (.22%)
Peritoneal And Retroperitoneal Cond...	14 (.22%)
Eye Therapeutic Procedures	13 (.21%)
Nervous System, Skull And Spine The...	13 (.21%)
Skin Vascular Abnormalities	13 (.21%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nitroglycerin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nitroglycerin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.